Viva Energy Group Limited (ASX: VEA) has posted strong full-year results for 2024, with Group EBITDA (RC) rising 5% to $748.6 million, driven by solid growth in Commercial & Industrial…
Nine Entertainment (ASX: NEC) Reports $1.4B Revenue for H1 FY25 Amid Market Challenges
Olympics, Streaming, and Cost Efficiencies Drive Performance Nine Entertainment Co. (ASX: NEC) has delivered its FY25 interim results, reporting $1.4 billion in revenue and $96 million in net profit after…
4DMedical (ASX: 4DX) Secures Regulatory Approval for CT LVAS™ in Canada
Expansion into Canadian Market Strengthens Global Footprint Respiratory imaging pioneer 4DMedical (ASX: 4DX) has just scored a major regulatory win, securing Health Canada approval for its CT Lung Ventilation Analysis…
Zip Co (ASX: ZIP) Reports Record H1 FY25 Earnings, Driven by U.S. Growth
Cash EBTDA More Than Doubles as Zip Strengthens Market Position Zip Co Limited (ASX: ZIP) has delivered a blockbuster first half for FY25, with cash EBTDA surging 117.1% to $67…
Domino’s Delivers Mixed H1 FY2025 Results Amid Strategic Reset
Australia and Benelux Shine, Japan and France Struggle as Domino’s Focuses on Profitability Domino’s Pizza Enterprises Ltd (ASX: DMP) has reported half-year FY2025 results, with EBIT of $100.6 million, a…
Kogan Returns to Strong Growth in 1H FY25
Kogan.com Ltd (ASX: KGN) has posted an impressive first-half FY25 result, with both sales and profitability climbing as the company capitalized on strategic initiatives and an optimized marketing approach. Group…
nib Reports Strong Policyholder Growth Despite Earnings Dip in 1H25
nib Holdings (ASX: NHF) has delivered a mixed first-half result for FY25, with revenue rising but earnings taking a hit as margins normalise. The health insurer continues to outpace industry…
4DMedical Secures $5.5M Placement and Launches $7M Underwritten Share Purchase Plan
4DMedical Limited (ASX:4DX), a leader in respiratory imaging technology, has successfully raised $5.5 million through a share placement to institutional and sophisticated investors. The company is also launching a $7…
Neuren Secures Rare Pediatric Disease Designation for NNZ-2591
Neuren Pharmaceuticals (ASX: NEU) has achieved another key regulatory milestone, receiving Rare Pediatric Disease Designation from the US FDA for its investigational drug NNZ-2591 in Pitt Hopkins syndrome (PTHS) and…
WiseTech Global Board Shake-Up and Guidance Update
WiseTech Global (ASX: WTC) has announced significant Board changes, with four independent non-executive directors—Lisa Brock, Richard Dammery, Michael Malone, and Fiona Pak-Poy—stepping down. Their decision follows irreconcilable differences within the…